Blend Labs Inc (BLND) concluded trading on Wednesday at a closing price of $3.11, with 4.32 million shares of worth about $13.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -15.26% during that period and on March 05, 2025 the price saw a gain of about 5.07%. Currently the company’s common shares owned by public are about 254.43M shares, out of which, 204.16M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Stock saw a price change of -14.56% in past 5 days and over the past one month there was a price change of -17.51%. Year-to-date (YTD), BLND shares are showing a performance of -26.13% which increased to 13.09% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.08 but also hit the highest price of $5.53 during that period. The average intraday trading volume for Blend Labs Inc shares is 3.22 million. The stock is currently trading -15.28% below its 20-day simple moving average (SMA20), while that difference is down -18.35% for SMA50 and it goes to -14.01% lower than SMA200.
Blend Labs Inc (NYSE: BLND) currently have 254.43M outstanding shares and institutions hold larger chunk of about 51.74% of that.
The stock has a current market capitalization of $795.94M and its 3Y-monthly beta is at 1.40. It has posted earnings per share of -$0.24 in the same period. It has Quick Ratio of 3.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLND, volatility over the week remained 8.93% while standing at 6.17% over the month.
Stock’s fiscal year EPS is expected to rise by 139.28% while it is estimated to increase by 131.85% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JMP Securities on December 18, 2024 offering a Mkt outperform rating for the stock and assigned a target price of $7 to it. Coverage by Canaccord Genuity stated Blend Labs Inc (BLND) stock as a Buy in their note to investors on August 12, 2024, suggesting a price target of $4.75 for the stock. On August 09, 2024, William Blair Upgrade their recommendations, while on December 20, 2023, Wells Fargo Upgrade their ratings for the stock with a price target of $3.50. Stock get a Mkt perform rating from Keefe Bruyette on November 14, 2022.
